Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. ATLRx, Inc.
WARNING LETTER
•ATLRx, Inc.•May 4, 2022

ATLRx, Inc. – FDA Warning Letter, May 4, 2022

Record Details

On May 4, 2022, the FDA issued a Warning Letter to Chase Slappey regarding products sold on www.atlrx.com and associated social media. The FDA's February 2022 review found that the company markets various human and animal products containing CBD or Delta-8 THC, making unapproved drug claims.

Violations include: - **Unapproved New Human Drugs:** Products like "Delta 8 Terpene Gummies," "CBD Sleep Gummies," and "CBD Oil Tincture" are marketed with drug claims (e.g., for pain, anxiety, sleep) but lack FDA approval, violating sections 505(a) and 301(d) of the FD&C Act. - **Misbranded Human Drugs:** These human CBD/Delta-8 THC products are misbranded under section 502(f)(1) due to inadequate directions for use, as they address conditions not amenable to self-diagnosis/treatment. - **Adulterated Human Foods (CBD/Delta-8 THC):** Products like "CBD Sleep Gummies" and "Delta 8 Chocolate" are considered adulterated under section 402(a)(2)(C)(i) because CBD and Delta-8 THC are unapproved and unsafe food additives. Introducing food with added CBD is also a prohibited act under section 301(ll). - **Unapproved New Animal Drugs

Company
ATLRx, Inc.
Inspection date
May 4, 2022
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Ann M. Oxenham (Director)
  • Donald D. Ashley (Director)
  • Neal Bataller (Division Director)
View Company Profile

ID · 422ab777-fee9-4b5e-afd9-2f5bc8a0057c

Violation Codes10
21 U.S.C. 331(a)21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 352(f)(1)21 U.S.C. 360b(a)21 U.S.C. 351(a)(5)21 U.S.C. 342(a)(2)(C)(i)21 U.S.C. 331(ll)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore ATLRx, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.